Xact Kapitalforvaltning’s Ionis Pharmaceuticals IONS Stock Holding History

Xact Kapitalforvaltning’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.05M	Hold	22,311	–	–	0.02%	489
2019 Q4	$1.35M	Hold	22,311	–	–	0.02%	518
2019 Q3	$1.34M	Hold	22,311	–	–	0.03%	482
2019 Q2	$1.43M	Hold	22,311	–	–	0.03%	449
2019 Q1	$1.81M	Hold	22,311	–	–	0.04%	400
2018 Q4	$1.21M	Buy	22,311 +2,600	+13%	+$133K	0.03%	481
2018 Q3	$1.02M	Buy	19,711 +800	+4%	+$37.6K	0.02%	577
2018 Q2	$788K	Buy	18,911 +2,000	+12%	+$88.7K	0.02%	681
2018 Q1	$745K	Buy	16,911 +5,000	+42%	+$254K	0.02%	642
2017 Q4	$599K	Buy	+11,911	New	+$653K	0.01%	633

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Xact Kapitalforvaltning's IONS Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Ionis Pharmaceuticals (IONS) position steady in Q1 2020 at 22,311 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #489.

Xact Kapitalforvaltning first reported a position in IONS in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.81M in Q1 2019. 363 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

Xact Kapitalforvaltning held 22,311 shares of Ionis Pharmaceuticals worth $1.05M as of Q1 2020.
Xact Kapitalforvaltning left its Ionis Pharmaceuticals share count unchanged in Q1 2020.
Ionis Pharmaceuticals made up 0.02% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #489 holding.
Xact Kapitalforvaltning first reported a position in Ionis Pharmaceuticals in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Ionis Pharmaceuticals position peaked at $1.81M in Q1 2019.
363 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.